EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Acenocoumarol (Primary)
- Indications Deep vein thrombosis; Pulmonary embolism; Stroke; Thromboembolism
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms EU-PACT-Acenocoumarol; EUPACT-Acenocoumarol
- 18 Jun 2013 Biomarkers information updated
- 01 Jun 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 21 Feb 2013 New trial record